Short Interest in MariMed Inc. (OTCMKTS:MRMD) Drops By 43.6%

MariMed Inc. (OTCMKTS:MRMD) was the target of a significant decline in short interest during the month of March. As of March 13th, there was short interest totaling 14,026 shares, a decline of 43.6% from the February 26th total of 24,883 shares. Based on an average daily trading volume, of 679,274 shares, the days-to-cover ratio is presently 0.0 days. Currently, 0.0% of the shares of the stock are sold short.

MariMed Stock Down 2.8%

Shares of MariMed stock opened at $0.08 on Friday. The company has a market capitalization of $30.15 million, a P/E ratio of -2.53 and a beta of 1.11. The company has a debt-to-equity ratio of 1.44, a current ratio of 1.00 and a quick ratio of 0.38. The business has a 50-day moving average of $0.08 and a two-hundred day moving average of $0.10. MariMed has a 1 year low of $0.07 and a 1 year high of $0.23.

Analysts Set New Price Targets

Separately, Zacks Research upgraded MariMed from a “strong sell” rating to a “hold” rating in a research report on Thursday, January 1st. One equities research analyst has rated the stock with a Strong Buy rating and two have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy”.

MariMed Company Profile

MariMed Inc is a multi?state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult?use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre?rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.